Home > Riviste > Minerva Gastroenterologica e Dietologica > Fascicoli precedenti > Articoli online first > Minerva Gastroenterologica e Dietologica 2016 Oct 21

ULTIMO FASCICOLOMINERVA GASTROENTEROLOGICA E DIETOLOGICA

Rivista di Gastroenterologia, Nutrizione e Dietetica


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

Minerva Gastroenterologica e Dietologica 2016 Oct 21

Update on hepatitis C treatment: systematic review of clinical trials

Manan JHAVERI, Nicholas PROCACCINI, Kris V. KOWDLEY

Liver Care Network and Organ Care Research, Swedish Medical Center, Seattle, WA, USA


PDF  ESTRATTI


Chronic Hepatitis C is a major public health problem. The chronicity of the Hepatitis C can lead to advanced liver disease, cirrhosis and even hepatocellular carcinoma. Chronic hepatitis C is the leading indication of for liver transplantation in the United States. Since the introduction of directly acting antiviral agents (DAAs), there have been there have been dramatic advances in treatment of hepatitis C in terms of tolerability, duration of therapy with significant increases in the rates of sustained virology response (SVR). This review summarizes the findings of recently published clinical trials of DAAs in the treatment of hepatitis C by genotype and in patients co-infected with HCV / HIV.

inizio pagina